Functional Expression and Impact of Testis-specific Gene Antigen 10 in Breast Cancer: a Combined in Vitro and in Silico Analysis
Overview
Authors
Affiliations
Testis-specific gene antigen 10 () is a less-known gene, which is involved in the vague biological paths of different cancers. Here, we investigated the expression using different concentrations of glucose under hypoxia and also its interaction with the hypoxia-inducible factor 1 (HIF-1). The breast cancer MDA-MB-231 and MCF-7 cells were cultured with different concentrations of glucose (5.5, 11.0 and 25.0 mM) under normoxia/hypoxia for 24, 48, and 72 hours and examined for the HIF-1α expression and cell migration by Western blotting and scratch assays. The qPCR was employed to analyze the expression of . Three-dimensional (3D) structure and the energy minimization of the interacting domain of TSGA10 were performed by MODELLER 9.17 and Swiss-PDB viewer v4.1.0/UCSF Chimera v1.11. The UCSF Chimera 1.13.1 and Hex 6.0 were used for the molecular docking simulation. The Cytoscape 3.7.1 and STRING v11.0 were used for protein-protein interaction (PPI) network analysis. The HIF-1a related hypoxia pathways were obtained from BioModels database and reconstructed in CellDesigner v4.4.2. The increased expression of TSGA10 was found to be significantly associated with the reduced metastasis in the MDA-MB-231 cells, while an inverse relationship was seen between the mRNA level and cellular migration but not in the MCF-7 cells. The C-terminal domain of interacted with HIF-1α with high affinity, resulting in PPI network with 10 key nodes ( and ). Collectively, TSGA10 functional expression alters under the hyper-/hypo-glycemia and hypoxia, which indicates its importance as a candidate bio-target for the cancer therapy.
Prediction the functional impacts of highly deleterious non-synonymous variants of gene.
Jamali Z, Zargar M, Modarressi M Mol Biol Res Commun. 2025; 14(1):47-58.
PMID: 39744514 PMC: 11624612. DOI: 10.22099/mbrc.2024.49991.1977.
Godiyal Y, Maheshwari D, Taniguchi H, Zinzuwadia S, Morera-Diaz Y, Tewari D Mil Med Res. 2024; 11(1):82.
PMID: 39690423 PMC: 11654217. DOI: 10.1186/s40779-024-00586-9.
Taghizadeh-Hesary F, Ghadyani M, Kashanchi F, Behnam B Cancers (Basel). 2024; 16(17).
PMID: 39272902 PMC: 11393850. DOI: 10.3390/cancers16173044.
Asghar S, Mushtaq N, Ahmed A, Anwar L, Munawar R, Akhtar S Molecules. 2024; 29(2).
PMID: 38276568 PMC: 10820890. DOI: 10.3390/molecules29020490.
Eldakhakhny B, Al Sadoun H, Choudhry H, Mobashir M Front Endocrinol (Lausanne). 2021; 12:641888.
PMID: 33927693 PMC: 8078136. DOI: 10.3389/fendo.2021.641888.